Cargando…
Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
Clozapine remains the only drug treatment likely to benefit patients with treatment resistant schizophrenia. Its use is complicated by an increased risk of neutropenia and so there are stringent monitoring requirements and restrictions in those with previous neutropenia from any cause or from clozap...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275543/ https://www.ncbi.nlm.nih.gov/pubmed/32503471 http://dx.doi.org/10.1186/s12888-020-02592-2 |